Related Experiment Video
Updated: Feb 22, 2026

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
Procoagulant activity during viral infections.
Saravanan Subramaniam1, Inge Scharrer2
1Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, USA.
Viral infections can cause inflammation, leading to an imbalance in blood clotting and increasing the risk of thrombosis. Understanding these mechanisms is crucial for managing viral diseases and preventing complications.
Area of Science:
- Immunology
- Hematology
- Virology
Background:
- Inflammation during viral infections disrupts the balance between pro-coagulant and anti-coagulant states.
- Endothelial dysfunction in systemic viral infections critically impacts hemostasis and can lead to organ failure.
- Elevated plasma markers like TAT, D-dimer TF-positive MPs, and vWF indicate a prothrombotic state during viral infections.
Purpose of the Study:
- To review the pathological mechanisms linking viral infections to a prothrombotic state.
- To discuss the role of tissue factor (TF)-dependent coagulation activation in viral infections.
- To explore Toll-like receptors (TLRs) signaling pathways activated by viral infections and their contribution to coagulation.
Main Methods:
- Literature review focusing on TF-dependent coagulation and TLR signaling in viral infections.
- Analysis of studies investigating procoagulant markers (TAT, D-dimer TF-positive MPs, vWF) in viral infections.
- Discussion of cell type- and species-specific TLR activation and its impact on research models.
Main Results:
- Viral infections induce inflammation that skews hemostasis towards a prothrombotic state.
- Endothelial activation and dysfunction are key contributors to organ failure during systemic viral infections.
- TLR activation by viruses is complex and varies by cell type and species, complicating direct translation of animal model findings to humans.
Conclusions:
- The procoagulant response during viral infections is multifactorial, involving inflammation, endothelial dysfunction, and specific signaling pathways.
- Further research is needed to fully elucidate the pathological mechanisms underlying viral infection-associated thrombosis.
- Understanding these mechanisms is vital for developing targeted therapies to mitigate thrombotic complications in viral diseases.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Venous Thrombosis III: Interprofessional Care
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

